Bioteque Corporation is a medical device manufacturer specializing in the development and production of hemodialysis consumables, intravascular treatment materials, and other medical supplies. The company manufactures a full range of TPU (thermoplastic polyurethane) indwelling catheters, including pigtail drainage catheter sets, double-J ureteral drainage catheter sets, percutaneous transhepatic biliary drainage catheters, percutaneous nephrostomy drainage catheter sets, and hemodialysis catheter sets. Its intravascular interventional radiology product line includes vascular dilation balloon catheters, vascular angiography catheters, guiding sheaths, CT/MRI contrast injection syringe sets, microcatheters, and hydrophilic guidewires. Bioteque operates manufacturing facilities in Taiwan and the Philippines and provides contract development and manufacturing organization (CDMO) services. The company holds patents covering various medical applications and collaborates with research institutions for new product development. Founded in 1991, Bioteque was listed on the OTC market in 2002.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Medical Devices Homepage bioteq.com.tw/zh-tw
Sector Healthcare IR page bioteq.com.tw/zh-tw/page-categories/investors
Tags
hemodialysis, catheters, interventional radiology, tpu, cdmo, medical consumables, BIOTEQUE
Press page —

Metrics

Valuation  
Market cap NT$ 7.277B
Market cap (USD) $ 220.863M
P/E 12.00
PEG 4.01
P/BV 1.98
P/S 3.19
P/OCF 10.36
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 15.3%
ROI 14.9%
ROIC 14.9%
Profit margin 25.2%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 3.0%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 37.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 2.135B 2.073B 1.945B 2.01B 1.825B 1.948B 1.859B 1.613B 1.42B 1.407B 1.259B 1.124B 957.883M 842.308M 760.314M 821.623M
Net profit 539.185M 528.26M 452.55M 493.54M 431.257M 488.665M 464.172M 404.997M 303.939M 358.232M 315.766M 290.902M 215.224M 166.308M 128.597M 172.587M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 120.5 — — — — — — — — — — — — — — —
P/S 3.91 — — — — — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Bioteque Corporation (ticker 4107.TWO), listed in Taiwan.

ETFs Holding Bioteque Corporation

ETF Weight in ETF Shares Market value As of
DEXC 0.00% 3,000 $ 9,645.28 Nov 12, 2026
DFEV 0.00% 23,000 $ 73.947K Nov 12, 2026
DFEM 0.00% 70,000 $ 225.056K Nov 12, 2026
DFSE 0.00% 3,000 $ 9,645.28 Nov 12, 2026
DFAE 0.00% 30,000 $ 96.453K Nov 12, 2026
DFAX 0.00% 36,000 $ 115.743K Nov 12, 2026
AVEM 0.00% 27,000 $ 85.5K Nov 16, 2026
AVES 0.00% 1,000 $ 3,166.66 Nov 16, 2026
AVSE 0.00% 1,000 $ 3,166.66 Nov 16, 2026
AVEE 0.00% 1,000 $ 3,166.66 Nov 16, 2026